Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Plos One|May 16, 2024
Navigating regulatory landscape: A qualitative exploration of medical devices and in vitro diagnostic medical devices oversight in Zimbabwe through key stakeholder perspectivesCharles Chiku, Talkmore Maruta, Fredrick Mbiba, et al.Plos One|May 16, 2024
Assessing operational readiness: Regulatory landscape and compliance in zimbabwe for medical devices and in vitro diagnostic medical devicesCharles Chiku, Talkmore Maruta, Fredrick Mbiba, et al.The Pan African Medical Journal|November 19, 2021
Rapid HIV-1 drug resistance testing in a resource limited setting: the Pan Degenerate Amplification and Adaptation assay (PANDAA)Vinie Kouamou, Chiratidzo Ellen Ndhlovu, David Katzenstein, et al.Viruses|September 28, 2023
Low Prevalence of Pre-Treatment and Acquired Drug Resistance to Dolutegravir among Treatment Naïve Individuals Initiating on Tenofovir, Lamivudine and Dolutegravir in ZimbabweVinie Kouamou, Tendai Washaya, Chiratidzo Ellen Ndhlovu, et al.Journal of Medical Virology|August 21, 2013
High level of HIV-2 false positivity in KwaZulu-Natal province: a region of South Africa with a very high HIV-1 subtype C prevalenceLavanya Singh, Raveen Parboosing, Justen Manasa, et al.AIDS (London, England)|January 16, 2024
Virological, weight, and drug resistance outcomes among patients initiating a dolutegravir-based first-line antiretroviral therapy regimen in ZimbabweVinie Kouamou, Tendai Washaya, Tichaona Mapangisana, et al.The Pan African Medical Journal|October 28, 2021
SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunityVinie Kouamou, Richard Matarise, Elizabeth Dos Santos, et al.AIDS Research and Human Retroviruses|September 14, 2017
Community Based Antiretroviral Treatment in Rural ZimbabweBenjamin Chimukangara, Justen Manasa, Rebecca Mitchell, et al.Clinical and Vaccine Immunology : CVI|February 3, 2007
Evaluation of the Partec flow cytometer against the BD FACSCalibur system for monitoring immune responses of human immunodeficiency virus-infected patients in ZimbabweJusten Manasa, Hazvineyi Musabaike, Collen Masimirembwa, et al.Viruses|July 2, 2021
HIV-1 Drug Resistance Genotyping in Resource Limited Settings: Current and Future Perspectives in Sequencing TechnologiesSontaga Manyana, Lilishia Gounder, Melendhran Pillay, et al.Pageof 7